Moody Aldrich Partners LLC Invests $2.24 Million in Quanterix Corp (NASDAQ:QTRX)

Moody Aldrich Partners LLC acquired a new stake in shares of Quanterix Corp (NASDAQ:QTRX) in the second quarter, Holdings Channel reports. The firm acquired 81,702 shares of the company’s stock, valued at approximately $2,238,000.

Other institutional investors also recently added to or reduced their stakes in the company. Silvercrest Asset Management Group LLC increased its position in shares of Quanterix by 16.3% during the first quarter. Silvercrest Asset Management Group LLC now owns 274,373 shares of the company’s stock worth $5,040,000 after acquiring an additional 38,357 shares during the period. Frontier Capital Management Co. LLC purchased a new position in shares of Quanterix during the first quarter worth approximately $9,693,000. Bank of New York Mellon Corp increased its position in shares of Quanterix by 21.8% during the first quarter. Bank of New York Mellon Corp now owns 251,667 shares of the company’s stock worth $4,623,000 after acquiring an additional 45,090 shares during the period. Citigroup Inc. increased its holdings in Quanterix by 18.4% during the first quarter. Citigroup Inc. now owns 5,851 shares of the company’s stock valued at $107,000 after buying an additional 910 shares during the period. Finally, Alliancebernstein L.P. increased its holdings in Quanterix by 20.0% during the first quarter. Alliancebernstein L.P. now owns 20,400 shares of the company’s stock valued at $375,000 after buying an additional 3,400 shares during the period. 69.28% of the stock is owned by institutional investors.

In other news, Director Martin D. Madaus sold 1,600 shares of Quanterix stock in a transaction on Tuesday, July 21st. The shares were sold at an average price of $31.45, for a total transaction of $50,320.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO E Kevin Hrusovsky sold 5,000 shares of Quanterix stock in a transaction on Wednesday, May 6th. The stock was sold at an average price of $27.09, for a total transaction of $135,450.00. The disclosure for this sale can be found here. Insiders sold 61,116 shares of company stock worth $1,657,246 over the last ninety days. Corporate insiders own 25.40% of the company’s stock.

NASDAQ QTRX traded down $0.87 on Friday, hitting $32.31. The stock had a trading volume of 690,626 shares, compared to its average volume of 188,982. The business’s fifty day moving average price is $27.76 and its 200 day moving average price is $24.80. The company has a debt-to-equity ratio of 0.06, a current ratio of 6.80 and a quick ratio of 6.17. Quanterix Corp has a 52-week low of $10.90 and a 52-week high of $35.76. The stock has a market cap of $914.73 million, a price-to-earnings ratio of -20.07 and a beta of 1.77.

Quanterix (NASDAQ:QTRX) last released its quarterly earnings results on Tuesday, May 5th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.36) by ($0.03). Quanterix had a negative return on equity of 36.97% and a negative net margin of 70.51%. The firm had revenue of $15.73 million during the quarter, compared to analysts’ expectations of $12.70 million. As a group, sell-side analysts anticipate that Quanterix Corp will post -1.67 EPS for the current year.

Several equities analysts recently issued reports on the stock. Zacks Investment Research lowered shares of Quanterix from a “buy” rating to a “hold” rating in a report on Wednesday, June 10th. BidaskClub raised shares of Quanterix from a “strong sell” rating to a “sell” rating in a report on Friday. Finally, Canaccord Genuity reissued a “buy” rating and set a $36.00 price objective on shares of Quanterix in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $33.67.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Simoa HD-1 instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids.

Featured Article: Return on Investment (ROI)

Want to see what other hedge funds are holding QTRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quanterix Corp (NASDAQ:QTRX).

Institutional Ownership by Quarter for Quanterix (NASDAQ:QTRX)

Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.